| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |